Clinical Trial Update: Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating oral alfacalcidol for effects on coronary artery calcification in predialysis chronic kidney disease; the trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Calcification
• Vascular Calcification

Drugs mentioned

• Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Vascular Calcification | Phase 2 | Status: UNKNOWN